Exelixis Inc (EXEL)
37.73
+0.01
(+0.03%)
USD |
NASDAQ |
Mar 25, 16:00
37.70
-0.03
(-0.08%)
After-Hours: 20:00
Exelixis Price to Book Value: 4.705 for March 25, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Halozyme Therapeutics Inc | 21.96 |
| Biomarin Pharmaceutical Inc | 2.413 |
| Incyte Corp | 3.485 |
| Catalyst Pharmaceuticals Inc | 4.292 |
| Blueprint Medicines Corp | 19.93 |
Price to Book Value Related Metrics
| PE Ratio | 21.32 |
| PS Ratio | 5.152 |
| PEG Ratio | 0.1217 |
| Price to Free Cash Flow | 17.63 |
| Price | 37.73 |
| Earnings Yield | 4.69% |
| Market Cap | 10.56B |
| PEGY Ratio | 0.1217 |
| Operating PE Ratio | 16.19 |
| Normalized PE Ratio | 18.97 |